FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

687311000001107: Raciran 150 tablets (Opus Pharmaceuticals) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16569701000001113 Raciran 150 tablets (Opus Pharmaceuticals) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41173201000001115 Raciran 150 tablets (Opus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Raciran 150 tablets (Opus Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Is a Raciran true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Raciran 150 tablets (Opus Pharmaceuticals) 60 tablet 6 x 10 tablets Is pack of False Raciran 150 tablets (Opus Pharmaceuticals) Inferred relationship Existential restriction modifier
Raciran 150 tablets (Opus Pharmaceuticals) 60 tablet 6 x 10 tablets Has AMP True Raciran 150 tablets (Opus Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start